Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Glasner, Ariella ^a   Isaacson, Batya ^a   Viukov, Sergey ^b   Neuman, Tzahi ^c   Friedman, Nehemya ^d,e   Mandelboim, Michal ^d,e   Sexl, Veronika ^f   Hanna, Jacob H ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d MINISTRY OF HEALTH   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

LY ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NCR1 PROTEIN, MOUSE;

ANIMAL; DISEASE MODEL; EXPERIMENTAL MELANOMA; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA; METABOLISM; MOUSE; NATURAL KILLER CELL; ORTHOMYXOVIRIDAE; PATHOGENICITY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, LY; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA, HUMAN; KILLER CELLS, NATURAL; MELANOMA, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; ORTHOMYXOVIRIDAE;

EID: 85031287959     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-12998-w     Document Type: Article

References (59)

1. Achdout, H. et al. Enhanced recognition of human NK receptors after influenza virus infection. J Immunol 171, 915-923 (2003).
2. Achdout, H., Manaster, I. & Mandelboim, O. Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. Journal of virology 82, 8030-8037, https://doi. org/10. 1128/JVI. 00870-08 (2008).
3. Achdout, H. et al. Killing of avian and Swine influenza virus by natural killer cells. Journal of virology 84, 3993-4001, https://doi. org/10. 1128/JVI. 02289-09 (2010).
4. Arnon, T. I. et al. Recognition of viral hemagglutinins by NKp44 but not by NKp30. European journal of immunology 31, 2680-2689, https://doi. org/10. 1002/1521-4141 (2001).
5. Babic, M. et al. Cytomegalovirus immunoevasin reveals the physiological role of "missing self " recognition in natural killer cell dependent virus control in vivo. The Journal of experimental medicine 207, 2663-2673, https://doi. org/10. 1084/jem. 20100921 (2010).
6. Bar-On, Y. et al. Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses. Cell reports 3, 1044-1050, https://doi. org/10. 1016/j. celrep. 2013. 03. 034 (2013).
7. Bar-On, Y., Seidel, E., Tsukerman, P., Mandelboim, M. & Mandelboim, O. Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors. The Journal of infectious diseases 210, 410-418, https://doi. org/10. 1093/infdis/ jiu094 (2014).
8. Gazit, R. et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nature immunology 7, 517-523, https://doi. org/10. 1038/ni1322 (2006).
9. Glasner, A. et al. Elucidating the mechanisms of influenza virus recognition by Ncr1. PloS one 7, e36837, https://doi. org/10. 1371/ journal. pone. 0036837 (2012).
10. Jarahian, M. et al. Modulation of NKp30-and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin. PLoS pathogens 7, e1002195, https://doi. org/10. 1371/journal. ppat. 1002195 (2011).
11. Jarahian, M. et al. Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. Journal of virology 83, 8108-8121, https://doi. org/10. 1128/JVI. 00211-09 (2009).
12. Chaushu, S. et al. Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease. PLoS pathogens 8, e1002601, https://doi. org/10. 1371/journal. ppat. 1002601 (2012).
13. Gur, C. et al. Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinAdependent killing of NK cells. Cell host & microbe 14, 664-674, https://doi. org/10. 1016/j. chom. 2013. 11. 004 (2013).
14. Vitenshtein, A. et al. NK Cell Recognition of Candida glabrata through Binding of NKp46 and NCR1 to Fungal Ligands Epa1, Epa6, and Epa7. Cell host & microbe 20, 527-534, https://doi. org/10. 1016/j. chom. 2016. 09. 008 (2016).
15. Arnon, T. I. et al. The mechanisms controlling the recognition of tumor-and virus-infected cells by NKp46. Blood 103, 664-672, https://doi. org/10. 1182/blood-2003-05-1716 (2004).
16. Elboim, M. et al. Tumor immunoediting by NKp46. J Immunol 184, 5637-5644, https://doi. org/10. 4049/jimmunol. 0901644 (2010).
17. Glasner, A. et al. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1. J Immunol 188, 2509-2515, https://doi. org/10. 4049/jimmunol. 1102461 (2012).
18. Glasner, A. et al. Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity. Cell Discov 1, 15036, https://doi. org/10. 1038/celldisc. 2015. 36 (2015).
19. Glasner, A. et al. Expression, Function, and Molecular Properties of the Killer Receptor Ncr1-Noe. J Immunol 195, 3959-3969, https://doi. org/10. 4049/jimmunol. 1501234 (2015).
20. Halfteck, G. G. et al. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1. J Immunol 182, 2221-2230, https://doi. org/10. 4049/jimmunol. 0801878 (2009).
21. Ghadially, H. et al. NK cell receptor NKp46 regulates graft-versus-host disease. Cell reports 7, 1809-1814, https://doi. org/10. 1016/j. celrep. 2014. 05. 011 (2014).
22. Gur, C. et al. NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut 61, 885-893, https:// doi. org/10. 1136/gutjnl-2011-301400 (2012).
23. Gur, C. et al. Recognition and Killing of Human and Murine Pancreatic {beta} Cells by the NK Receptor NKp46. J Immunol 187, 3096-3103, https://doi. org/10. 4049/jimmunol. 1101269 (2011).
24. Gur, C. et al. The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes. PloS one 8, e74033, https://doi. org/10. 1371/journal. pone. 0074033 (2013).
25. Ghadially, H. et al. NKp46 regulates allergic responses. European journal of immunology 43, 3006-3016, https://doi. org/10. 1002/ eji. 201343388 (2013).
26. Hanna, J. et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nature medicine 12, 1065-1074, https://doi. org/10. 1038/nm1452 (2006).
27. Koch, J., Steinle, A., Watzl, C. & Mandelboim, O. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends in immunology 34, 182-191, https://doi. org/10. 1016/j. it. 2013. 01. 003 (2013).
28. Karre, K. NK cells, MHC class I molecules and the missing self. Scandinavian journal of immunology 55, 221-228 (2002).
29. Cantoni, C. et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. European journal of immunology 29, 3148-3159, https://doi. org/10. 1002/(SICI)1521-4141 (1999).
30. Crocker, P. R., Paulson, J. C. & Varki, A. Siglecs and their roles in the immune system. Nature reviews. Immunology 7, 255-266, https://doi. org/10. 1038/nri2056 (2007).
31. Lankry, D. et al. Expression and function of CD300 in NK cells. J Immunol 185, 2877-2886, https://doi. org/10. 4049/ jimmunol. 0903347 (2010).
32. Markel, G. et al. CD66a interactions between human melanoma and NK cells: A novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol 168, 2803-2810 (2002).
33. Stanietsky, N. et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America 106, 17858-17863, https://doi. org/10. 1073/pnas. 0903474106 (2009).
34. Bauman, Y. et al. Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity. Oncotarget 7, 15369-15381, https://doi. org/10. 18632/oncotarget. 8085 (2016).
35. Bauman, Y. et al. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell host & microbe 9, 93-102, https://doi. org/10. 1016/j. chom. 2011. 01. 008 (2011).
36. Nachmani, D., Stern-Ginossar, N., Sarid, R. & Mandelboim, O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell host & microbe 5, 376-385, https://doi. org/10. 1016/j. chom. 2009. 03. 003 (2009).
37. Nachmani, D. et al. MicroRNA editing facilitates immune elimination of HCMV infected cells. PLoS pathogens 10, e1003963, https://doi. org/10. 1371/journal. ppat. 1003963 (2014).
38. Stern-Ginossar, N. et al. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nature immunology 9, 1065-1073, https://doi. org/10. 1038/ni. 1642 (2008).
39. Mandelboim, O. et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060, https://doi. org/10. 1038/35059110 (2001).
40. Diab, M. et al. NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection. European journal of immunology, https://doi. org/10. 1002/eji. 201646756 (2017).
41. Diab, M. et al. Suppression of human metapneumovirus (HMPV) infection by the innate sensing gene CEACAM1. Oncotarget, https://doi. org/10. 18632/oncotarget. 11979 (2016).
42. Gur, C. et al. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nature immunology 11, 121-128, https://doi. org/10. 1038/ni. 1834 (2010).
43. Gur, C. et al. Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack. Immunity 42, 344-355, https://doi. org/10. 1016/j. immuni. 2015. 01. 010 (2015).
44. Guerra, N. et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28, 571-580, https://doi. org/10. 1016/j. immuni. 2008. 02. 016 (2008).
45. Zafirova, B. et al. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2Ddeficient mice. Immunity 31, 270-282, https://doi. org/10. 1016/j. immuni. 2009. 06. 017 (2009).
46. Sheppard, S. et al. Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire. Blood 121, 5025-5033, https://doi. org/10. 1182/blood-2012-12-471607 (2013).
47. Eckelhart, E. et al. A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 117, 1565-1573, https://doi. org/10. 1182/blood-2010-06-291633 (2011).
48. Couzin-Frankel, J. Breakthrough of the year 2013. Cancer immunotherapy. Science 342, 1432-1433, https://doi. org/10. 1126/ science. 342. 6165. 1432 (2013).
49. Vanneman, M. & Dranoff, G. Combining immunotherapy and targeted therapies in cancer treatment. Nature reviews. Cancer 12, 237-251, https://doi. org/10. 1038/nrc3237 (2012).
50. Dudley, M. E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850-854, https://doi. org/10. 1126/science. 1076514 (2002).
51. Dal Porto, J. M., Burke, K. & Cambier, J. C. Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck. Immunity 21, 443-453, https://doi. org/10. 1016/j. immuni. 2004. 07. 018 (2004).
52. Yagita, H. et al. CD2 expression in murine B cell lineage. International immunology 1, 94-98 (1989).
53. Iliopoulou, E. G. et al. A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer. Cancer immunology, immunotherapy: CII 59, 1781-1789, https://doi. org/10. 1007/s00262-010-0904-3 (2010).
54. Ishikawa, E. et al. Autologous natural killer cell therapy for human recurrent malignant glioma. Anticancer research 24, 1861-1871 (2004).
55. Lundqvist, A., McCoy, J. P., Samsel, L. & Childs, R. Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors. Blood 109, 3603-3606, https://doi. org/10. 1182/ blood-2006-05-024315 (2007).
56. Miller, J. S. et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105, 3051-3057, https://doi. org/10. 1182/blood-2004-07-2974 (2005).
57. Lakshmikanth, T. et al. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. The Journal of clinical investigation 119, 1251-1263, https://doi. org/10. 1172/JCI36022 (2009).
58. Narni-Mancinelli, E. et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 335, 344-348, https://doi. org/10. 1126/science. 1215621 (2012).
59. Glasner, A., Isaacson, B. & Mandelboim, O. Expression and function of NKp46 W32R: The human homologous protein of mouse NKp46 W32R (Noe). Scientific reports 7, 40944, https://doi. org/10. 1038/srep40944 (2017).